Choose 1 option.
Cumulus Pharma's field sales reps use the Medical Insights feature in Agentforce Life Sciences for Customer Engagement to record insights from their engagements with Healthcare Providers (HCPs). Sales leadership determines that all reps in a territory can benefit from medical insights captured from HCPs in that territory.
Which out-of-the-box configuration makes it possible for reps in the same territory to collaborate on medical insights?
Option B, MedicalInsightSharingHandler, is correct because the requirement is about collaboration and access to medical insight records by users in the same territory. Salesforce Help describes the Medical Insights tab as enabling users to view their own insights as well as insights captured by users with the same profile within their territories. That means Life Sciences Cloud supports territory-based visibility for Medical Insights so that relevant field users can collaborate around insights collected from HCP engagements.
The key word in the question is ''collaborate.'' Collaboration requires record sharing, not merely record availability. MedicalInsightSharingHandler is the out-of-the-box configuration that aligns with sharing medical insight records across the appropriate users, such as reps associated with the same territory. MedicalInsightAvailabilityHandler is not the best answer because ''availability'' typically controls whether a feature, action, or object behavior is available in a given context; it does not directly describe record sharing between users. MedicalInsightTerritoryAvailabilityHandler is also not correct because the Salesforce-documented sharing behavior for Medical Insights is about viewing insights captured within the user's territories, and the named handler that most directly supports that requirement is the sharing handler.
Therefore, when Cumulus Pharma wants field sales reps in the same territory to access and collaborate on relevant HCP medical insights, the correct out-of-the-box configuration is MedicalInsightSharingHandler.
Currently there are no comments in this discussion, be the first to comment!